Ilka Wicke Dr. - Profile and Investment Details

Investor Profile

Ilka Wicke Dr. is a Corporate Venture Capital based in Hesse, Germany with a diverse investment portfolio that includes companies such as Aignostics, T3 Pharmaceuticals, Dopavision, Topas Therapeutics, Actym, eTheRNA immunotherapies, STAT-Dx, Rinri Therapeutics, Rigontec, Hookipa Pharma, Tacalyx, NBE-Therapeutics, Aelin Therapeutics, Okairos, ImCheck Therapeutics, Wellth, T-knife, Brainomix, Acousia Therapeutics, Rgenta Therapeutics, DiogenX, Cardior Pharmaceuticals, Delonix Bioworks, Bodyport, Ruipeng Pet Healthcare, Metabomed, ArmaGen Technologies, Rewind Therapeutics, HepaRegeniX, Perfood, Eyevensys, Promethera Biosciences, Sentien Biotechnologies, Amal Therapeutics, Vira Therapeutics, OncoMyx Therapeutics, Libra Therapeutics, Abalos Therapeutics, AgomAb Therapeutics. Over time, Ilka Wicke Dr. has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Ilka Wicke Dr. is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Hospitals, Wellness, Women Founded, Medical Testing, Chemical Engineering, Chemical, Life Science, Artificial Intelligence (AI), Biotech, Software, Healthcare, Biotechnology, Market Research, Health Diagnostics, Beauty, Innovation Management, Medical, Therapeutics, Advanced Materials, Machine Learning, Personal Health, Pharmaceuticals may find it worthwhile to explore potential connections with Ilka Wicke Dr., as their portfolio suggests a familiarity and interest in this area.

Understanding Ilka Wicke Dr.’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.